Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $283000.0.

  • Lucid Diagnostics' Other Working Capital Changes rose 16431.82% to $283000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 19691.52%. This contributed to the annual value of -$1.2 million for FY2024, which is 19991.38% down from last year.
  • Per Lucid Diagnostics' latest filing, its Other Working Capital Changes stood at $283000.0 for Q3 2025, which was up 16431.82% from $757000.0 recorded in Q2 2025.
  • Lucid Diagnostics' 5-year Other Working Capital Changes high stood at $916000.0 for Q2 2022, and its period low was -$992000.0 during Q4 2022.
  • Moreover, its 4-year median value for Other Working Capital Changes was -$94000.0 (2024), whereas its average is $4200.0.
  • As far as peak fluctuations go, Lucid Diagnostics' Other Working Capital Changes plummeted by 40985.92% in 2024, and later surged by 37035.71% in 2025.
  • Over the past 4 years, Lucid Diagnostics' Other Working Capital Changes (Quarter) stood at -$992000.0 in 2022, then surged by 89.72% to -$102000.0 in 2023, then rose by 7.84% to -$94000.0 in 2024, then soared by 401.06% to $283000.0 in 2025.
  • Its Other Working Capital Changes stands at $283000.0 for Q3 2025, versus $757000.0 for Q2 2025 and $185000.0 for Q1 2025.